JP Morgan Chase’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,200
Closed -$223K 7494
2025
Q2
$223K Buy
+4,200
New +$213K ﹤0.01% 5182
2024
Q4
Sell
-5,900
Closed -$402K 7476
2024
Q3
$402K Sell
5,900
-29,200
-83% -$1.65M ﹤0.01% 5049
2024
Q2
$1.48M Sell
35,100
-38,300
-52% -$2.11M ﹤0.01% 4002
2024
Q1
$5.07M Buy
+73,400
New +$4.64M ﹤0.01% 3096
2023
Q2
Sell
-1,200
Closed -$81K 7035
2023
Q1
$81K Sell
1,200
-25,800
-96% -$1.66M ﹤0.01% 5519
2022
Q4
$1.34M Buy
27,000
+20,300
+303% +$829K ﹤0.01% 3861
2022
Q3
$218K Buy
6,700
+1,200
+22% +$49.5K ﹤0.01% 4906
2022
Q2
$217K Hold
5,500
﹤0.01% 5037
2022
Q1
$385K Buy
+5,500
New +$402K ﹤0.01% 4859
2020
Q3
Sell
-32,200
Closed -$2.8M 5546
2020
Q2
$2.8M Hold
32,200
﹤0.01% 2881
2020
Q1
$1.87M Sell
32,200
-1,011,700
-97% -$82.1M ﹤0.01% 3014
2019
Q4
$96.5M Buy
+1,043,900
New +$91.8M 0.02% 680
2019
Q3
Sell
-27,000
Closed -$3.11M 5792
2019
Q2
$3.11M Buy
27,000
+7,000
+35% +$705K ﹤0.01% 3051
2019
Q1
$1.73M Buy
+20,000
New +$1.7M ﹤0.01% 3429
2018
Q4
Sell
-57,000
Closed -$4.5M 5747
2018
Q3
$4.5M Buy
+57,000
New +$3.72M ﹤0.01% 2825
2018
Q2
Sell
-27,000
Closed -$1.09M 5571
2018
Q1
$1.09M Sell
27,000
-13,000
-33% -$634K ﹤0.01% 3630
2017
Q4
$2.1M Buy
+40,000
New +$2.14M ﹤0.01% 3293
2015
Q2
Sell
-1,000,000
Closed -$22M 4057
2015
Q1
$22M Hold
1,000,000
0.01% 1372
2014
Q4
$27.4M Hold
1,000,000
0.01% 1270
2014
Q3
$19.4M Buy
+1,000,000
New +$18.3M ﹤0.01% 1466

Other funds holding EXAS

JP Morgan Chase's EXAS Position: Q1 2026 in Review

JP Morgan Chase sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 674,621 shares — an estimated $68.5M sold.

JP Morgan Chase first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $1.41B in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • JP Morgan Chase reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • JP Morgan Chase sold 674,621 Exact Sciences shares in Q1 2026, an estimated $68.5M.
  • JP Morgan Chase first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • JP Morgan Chase's Exact Sciences position peaked at $1.41B in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.